Abstract
Over the past few decades, advances in the management and treatment of systemic lupus erythematosus have resulted in improved prognosis and greater survival rates. This period has also seen substantial increases in healthcare expenditure. Although improved outcomes offer some justification for an increase in costs, it remains important to examine whether limited healthcare resources are being used in a manner that is efficient and that provides the greatest benefit. The debate over how to organize, deliver and finance healthcare services is of great interest in many countries. Escalating costs, and the realization that existing healthcare systems may not be sustainable if current practices continue, have lent an increased urgency to this debate.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
